4//SEC Filing
Pierce Christopher 4
Accession 0001209191-21-026874
CIK 0001678660other
Filed
Apr 14, 8:00 PM ET
Accepted
Apr 15, 7:12 PM ET
Size
8.7 KB
Accession
0001209191-21-026874
Insider Transaction Report
Form 4
Pierce Christopher
EVP and Chief of Business Oper
Transactions
- Sale
Common Stock
2021-04-08$40.00/sh−200$8,000→ 3,750 total - Award
Common Stock
2021-04-08$1.89/sh+200$378→ 3,950 total - Exercise/Conversion
Employee Stock Option (right to buy)
2021-04-08−200→ 7,618 totalExercise: $1.89Exp: 2030-03-26→ Common Stock (200 underlying)
Footnotes (2)
- [F1]The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- [F2]The stock option is fully vested.
Documents
Issuer
Prelude Therapeutics Inc
CIK 0001678660
Entity typeother
Related Parties
1- filerCIK 0001824631
Filing Metadata
- Form type
- 4
- Filed
- Apr 14, 8:00 PM ET
- Accepted
- Apr 15, 7:12 PM ET
- Size
- 8.7 KB